Viriom

1 known investors

Viriom Inc. develops a pipeline of treatments for infectious diseases (blood-borne and respiratory viral diseases) and malignant diseases (solid tumors) through a global drug development platform built with partner networks. The company aims to broaden access to new therapies in both developed and developing countries.